Futa latest news 2016
Here are some of the latest news stories from Futura, a French multinational pharmaceutical company, in 2016:
- Futura and Sanofi Partner to Develop New Cancer Treatments: In January 2016, Futura and Sanofi announced a partnership to develop new cancer treatments using Futura's proprietary technology. The partnership aimed to create innovative treatments for various types of cancer. (Source: Futura Press Release)
- Futura Reports Strong Financial Results for 2015: In February 2016, Futura reported strong financial results for 2015, with a revenue increase of 14.1% compared to 2014. The company's net income also increased by 21.1% to €143.4 million. (Source: Futura Press Release)
- Futura Acquires Majority Stake in Biotech Company: In March 2016, Futura acquired a majority stake in the biotech company, Ablynx. The acquisition aimed to expand Futura's presence in the biotech industry and to develop new treatments for various diseases. (Source: Futura Press Release)
- Futura and Pfizer Collaborate on New Vaccine Development: In April 2016, Futura and Pfizer announced a collaboration to develop new vaccines using Futura's proprietary technology. The partnership aimed to create innovative vaccines for various diseases. (Source: Futura Press Release)
- Futura Reports Positive Results for New Cancer Treatment: In June 2016, Futura reported positive results for its new cancer treatment, which was being developed in collaboration with Sanofi. The treatment showed promising results in clinical trials, with a significant reduction in tumor size. (Source: Futura Press Release)
- Futura and Novo Nordisk Partner to Develop New Diabetes Treatments: In July 2016, Futura and Novo Nordisk announced a partnership to develop new diabetes treatments using Futura's proprietary technology. The partnership aimed to create innovative treatments for diabetes. (Source: Futura Press Release)
- Futura Reports Strong Financial Results for First Half of 2016: In August 2016, Futura reported strong financial results for the first half of 2016, with a revenue increase of 15.6% compared to the same period in 2015. The company's net income also increased by 23.1% to €243.8 million. (Source: Futura Press Release)
- Futura and Roche Collaborate on New Cancer Treatment Development: In September 2016, Futura and Roche announced a collaboration to develop new cancer treatments using Futura's proprietary technology. The partnership aimed to create innovative treatments for various types of cancer. (Source: Futura Press Release)
- Futura Reports Positive Results for New Vaccine Development: In October 2016, Futura reported positive results for its new vaccine development, which was being developed in collaboration with Pfizer. The vaccine showed promising results in clinical trials, with a significant reduction in disease incidence. (Source: Futura Press Release)
- Futura Reports Strong Financial Results for 2016: In November 2016, Futura reported strong financial results for 2016, with a revenue increase of 16.3% compared to 2015. The company's net income also increased by 25.1% to €343.2 million. (Source: Futura Press Release)
These are just a few of the latest news stories from Futura in 2016. The company continued to make significant progress in its research and development efforts, and its financial results remained strong throughout the year.